August 01, 2022
Article
At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.
July 28, 2022
Implicating adenovirus for hepatitis of unknown cause in children is confounded by its absence in some cases, and from all tested hepatic tissue.
Viral hepatitis “can and should be managed within primary care,” says Dr. Thomas Robertson.
July 19, 2022
2 patients died of Marburg virus in the southern Ashanti region of Ghana. Nearly 100 close contacts are now under observation for the infectious disease, which is a cousin of the Ebola virus.
June 27, 2022
The investigational therapy’s data points to a path towards a potential functional cure.
April 26, 2022
A shorter dosing period and no extra risk of suffering acute myocardial infarction means the newer 2-dose hepatitis B vaccine is an attractive option for protection.
April 25, 2022
The cases are in the pediatric population and come from 11 countries in the WHO European Region and 1 country in the WHO Region of the Americas.
April 11, 2022
Injection drug users who received accessible care treatment at a syringe service program were almost 3 times as likely to complete their hepatitis C treatment than people who received usual care.
March 18, 2022
Podcast
People who use drugs face obstacles, like homelessness and stigma, that hinder their access to healthcare. Dr. Brianna Norton opened the Montefiore-NYHRE Clinic, a first-of its kind academic medical center, to serve marginalized people holistically and respectfully.
March 10, 2022
First-in-class triaminopyrimidine demonstrates antimalarial efficacy in first-in-human test of dosing, kinetics, and clearing parasite in infected volunteers.
HIV Associated with Rapid Age Acceleration, New Study Finds
Frozen Meat Pizzas Recalled Due to Possible Metal Contaminants
Novavax Seeks FDA Authorization for its COVID-19 Vaccine as Booster
Reinfection, Vaccination, and Post-Recovery Shots
